Clicky

Zhejiang Starry Pharm Co Ltd(603520)

Description: Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.


Keywords: Drugs Chemical Compounds Levofloxacin Benzamides Fluoroquinolone Antibiotics Iohexol Iopamidol Pazufloxacin Radiocontrast Agents

Home Page: www.starrypharm.com

Xianju modern industrial cluster
Xianju, 317300
China
Phone: 86 57 6877 18628


Officers

Name Title
Mr. Jian Hu GM, Acting Sec. of the Board of Directors & Director
Mr. Wei Ding Financial Mang.
Mr. Qinhu Fang Deputy Gen. Mang.
Ms. Wenjun Lu Deputy Gen. Mang.

Exchange: SHG

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 57.6667
Price-to-Book MRQ: 3.5476
Price-to-Sales TTM: 3.3356
IPO Date:
Fiscal Year End: December
Full Time Employees: 1818
Back to stocks